As Australia aims to roll out a COVID-19 vaccine to everyone age eligible, it means that a number of individuals may experience a serious adverse event following immunisation (AEFI). Supporting these vaccinees is important and providing compensation to individuals who have experienced a vaccine injury is a strategy that has been used widely, for a long period of time, in countries such as the United States, UK and New Zealand to promote vaccine confidence and maintain vaccination rates. It is not a concept designed to suggest causation or fault, but a scheme to promote trust in vaccination programs as well as provide vaccine manufacturers with the reassurance to produce vaccines without fear of legal action.

An example of a serious AEFI requiring hospitalisation is thrombosis with thrombocytopenia syndrome (TTS) following वैक्सजेव्रिया (एस्ट्राजेनेका), with the symptoms experienced resulting in a significant impact on a vaccine recipient.

The No Fault COVID-19 Indemnity Scheme is funded by the Commonwealth government and has been introduced to allow Australians who have been significantly impacted by an adverse event following a COVID-19 vaccine to apply for access to financial assistance. There is currently no compensation scheme within Australia for applications relating to non-COVID-19 vaccines.

What is involved?

The No Fault COVID-19 Indemnity Scheme will run for 2 years and cover the cost of injuries ($1,000 and above) in situations where a serious adverse reaction has been caused by a COVID-19 vaccination. A full list of qualifying conditions as well as harm not covered under the scheme can be found at COVID-19 vaccine claims scheme- Overview.

Any vaccine encounter which has occurred since February 2021 is covered under this scheme. Individuals vaccinated within Australia, as well as those overseas as part of the Australian Government Overseas Network (AGON) COVID-19 vaccine rollout managed by DFAT are eligible.

Which vaccines are covered under this scheme?

All TGA approved COVID-19 vaccines are covered under this scheme. कोमिरनेटी (फाइजर), Spikevax (Moderna), Vaxzevria (AstraZeneca) and नुवाक्सोविड (नोवावैक्स) are currently in use within Australia;. COVID-19 Vaccine Janssen is also approved by the TGA however is not in use in Australia.

How to make a claim

Affected individuals (or an individual acting on their behalf) can submit their interest in making a claim via Register your interest in the COVID-19 Vaccine Claims Scheme.

Each claim is assessed by independent experts for accuracy and legitimacy. Evidence required in a claim includes:

  • details of the injury (including any medical documentation relating to its likely relationship to a COVID-19 vaccination)
  • hospitalisation
  • medical costs
  • lost wages.


लेखक: Rachael McGuire (MVEC Education Nurse Coordinator), Nigel Crawford (Director SAEFVIC, Murdoch Children’s Research Institute) and Francesca Machingaifa (MVEC Education Nurse Coordinator)

द्वारा समीक्षित: राचेल मैकगायर (MVEC शिक्षा नर्स समन्वयक)

तारीख: फ़रवरी 1, 2022

नई जानकारी और टीके उपलब्ध होते ही इस अनुभाग की सामग्रियों को अद्यतन किया जाता है। मेलबर्न वैक्सीन एजुकेशन सेंटर (MVEC) कर्मचारी सटीकता के लिए नियमित रूप से सामग्रियों की समीक्षा करते हैं।

आपको इस साइट की जानकारी को अपने व्यक्तिगत स्वास्थ्य या अपने परिवार के व्यक्तिगत स्वास्थ्य के लिए विशिष्ट, पेशेवर चिकित्सा सलाह नहीं मानना चाहिए। टीकाकरण, दवाओं और अन्य उपचारों के बारे में निर्णय सहित चिकित्सा संबंधी चिंताओं के लिए, आपको हमेशा एक स्वास्थ्य देखभाल पेशेवर से परामर्श लेना चाहिए।